Latest Breaking News On - Servier pharmaceutical - Page 1 : comparemela.com

Pharmaceutical Giant Servier Ordered to Pay $460 Million Over Deaths Linked to Diabetes Drug

A French appeals court ordered Servier Pharmaceutical to pay damages totaling over $460 million in connection with a more than ten-year-long diabetes drug scandal.

France generalUnited statesQuincy jonCharles joseph oudinParis courtNational social security agencyWorld health organizationTech timesServier pharmaceuticalGiant servier orderedOver deaths linkedIts diabetes drugGetty imagesJean philippe setaJoseph oudinLatest omicron subvariant adding

Brain Cancer Therapeutics Market 2023-2030 by Segmentation Based on Product, Application and Region | Pfizer Inc , GlaxoSmithKline PLC, Novartis AG |

Brain Cancer Therapeutics Market 2023-2030 by Segmentation Based on Product, Application and Region | Pfizer Inc , GlaxoSmithKline PLC, Novartis AG |
medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomBristol myerDevelopment of resistanceBristol myers squibbWorld health organizationPurchase this premium research reportIvy brain tumor centerGovernment companiesPorters five forces analysisBrain cancerRising investmentsBrain cancer therapeutics marketCoherent marketSample copyIncreasing aging population

Servier leverages Mission Bio s Tapestri® Platform to uncover AML resistance mechanisms in pivotal TIBSOVO® (ivosidenib) clinical trial

Servier leverages Mission Bio s Tapestri® Platform to uncover AML resistance mechanisms in pivotal TIBSOVO® (ivosidenib) clinical trial
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesTodd druleyScott daigleMission bio pharma assay developmentAgilent technologiesMayfield fundDrug administrationMission bioMission bio incAnnual world clinical biomarkersServier pharmaceuticalPharma assay developmentWorld clinical biomarkersTranslational medicineChief medical officerNovo growth

These Clinical Results Are Good News for AstraZeneca

AstraZeneca shared positive interim results for Imfinzi plus chemotherapy in treating patients with advanced biliary tract cancer.

National cancer instituteData monitoring committeeIndependent data monitoring committeeServier pharmaceutical

FDA Approves NGS-Based Companion Diagnostic for Previously Treated IDH1-Mutated Cholangiocarcinoma

FDA Approves NGS-Based Companion Diagnostic for Previously Treated IDH1-Mutated Cholangiocarcinoma
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesSouth koreaGarret hamptonMauricio minottaSusan pandyaUnity lab servicesDrug administrationThermo fisherResearch useServier pharmaceuticalsFisher scientificThermo fisher scientific incOur missionAmerican cancer societyThermo fisher scientificOncomine dx target test